| Personal venture |
Managing Dir.-CEO: Yasri (Aziz) [founder, Ph.D., born 1966]
Sc.Dir.-CSO: Loget (Olivier) [Vet.D., ex-Synthelabo, Hazleton, CIT, DSM, Roche, Addex Pharma]
Chem.Dir.: Boriès (Cédric) [co-founder Azasynth, Ph.D. organic chemistry]
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): privately owned
Notes : in December 2010, the initial websites of the forming companies are still active under www.novadecision.com and www.azasynth.com ; foundation date of Oribase Pharma selected as that of Azasynth, i.e. only 1 month before Nova Decision | Turnover (M€) : 0.034 (2009), 0.18 (2008)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Studies
Position : Subcontractor
Company confirm : neutral |
